Herceptin (generic name: trastuzumab) is a monoclonal antibody used as a targeted therapy for breast cancer. It specifically binds to the HER2/neu receptor, which is overexpressed in some breast cancer cells, leading to inhibition of cancer cell growth and proliferation.
